Insights

Smarter specialty spend in inflammatory care: Why adherence-focused models matter

Sep 30, 2025

Learn how adherence-focused specialty pharmacy care models reduce avoidable costs and improve outcomes in inflammatory care.

Image
Pharmacist in white coat and glasses uses tablet in brightly lit pharmacy aisle.

Chronic inflammatory conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease (IBD) are among the fastest-growing drivers of specialty drug spend. As prevalence rises, so does the demand for long-term, high-cost therapies — placing increasing pressure on payers to manage costs while improving outcomes. 

Addressing these challenges requires a smarter approach to specialty trend – one that emphasizes clinical guidance, patient engagement, and reducing avoidable medical utilization. Emerging models that focus on tailored support for inflammatory conditions can help improve adherence and outcomes while also alleviating some of the financial strain across the health care system.

The cost burden of inflammatory conditions 

More than 12 million Americans live with chronic inflammatory diseases, including:

  • ~1.5M with rheumatoid arthritis
  • ~3M with IBD
  • ~8M with psoriasis

These conditions not only impact quality of life—they also drive disproportionate specialty drug spend. The average cost per specialty prescription exceeds $4,500, and in IBD alone, 71% of health care costs are attributed to prescription drugs, primarily biologics.

But the true cost goes beyond the medication. Nonadherence and suboptimal treatment utilization often lead to flares, disease progression, and increased reliance on high-cost services like ER visits and hospitalizations. In fact, chronic conditions account for 90% of the nation’s $4.5 trillion in annual health care expenditures.

Medication adherence: A critical lever for payers 

Medication nonadherence contributes to: 

  • 125,000 preventable deaths annually
  • 25% of hospitalizations
  • 50% of treatment failures 

For patients with inflammatory conditions, staying on therapy is essential — not just for symptom control, but for avoiding costly complications. According to the CDC, improving adherence could save the U.S. health care system billions annually by reducing hospitalizations, ER visits, and treatment failures.

How integrated care models are transforming outcomes in inflammatory conditions & improving medication adherence

The complexity of inflammatory therapies continues to challenge traditional care models, making adherence a critical determinant of patient outcomes and overall health care costs. Leading organizations are demonstrating that integrated, patient-centric approaches — combining clinical expertise, digital engagement, and social support—are redefining what success looks like in specialty care.

Recent data reinforces this shift. Multi-modal engagement strategies have been linked to 12% fewer emergency room visits22% fewer inpatient admissions, and an 8% reduction in overall medical costs for payers. These results underscore a broader industry trend: adherence is not just a clinical issue but a behavioral and social one, requiring solutions that address the full spectrum of patient needs.

As the health care landscape evolves, models that integrate technology, personalized outreach, and equity-driven support are setting a new standard — one that prioritizes both improved outcomes and sustainable cost management.

A strategic opportunity for payers 

As the inflammatory drug landscape continues to evolve, payers have a unique opportunity to bend the cost curve. But access to therapies alone isn’t enough. True value comes from ensuring patients are adherent, engaged, and supported throughout their journey. 

Explore how Accredo Specialty Pharmacy can help plan sponsors drive smarter specialty spend — starting with adherence. 

 DOWNLOAD WHITE PAPER

This article was created with the assistance of AI tools. It was reviewed, edited, and fact-checked by Evernorth's editorial team.

Tags
Specialty
See how our solutions can help
Accredo Specialty Pharmacy

Evernorth’s Accredo Specialty Pharmacy raises the standard in specialty pharmacy, delivering care beyond the prescription and additive savings beyond the trend. Through our pharmacy model, plan sponsors can count on competitive specialty drug pricing and access to the specialty therapies your members need. We provide condition- and drug-focused expertise that prepares you for what’s ahead while driving the most value for you now. Our pharmacy engine propels savings to you and delivers well-being support for your members at no cost.

Related Articles
Image
Two women in white shirts smiling and walking together in a sunlit park.
Article
Understanding and addressing caregiver distress in oncology care
May 11, 2026
Image
Smiling woman doctor with stethoscope around neck, holding tablet talking to woman
Article
Why integrating behavioral health into cancer care matters for health plans
May 07, 2026
Image
black male in lab
Article
Cell and gene therapy pipeline outlook for plan sponsors
May 01, 2026